Evidence map›Paper›PMID 42455171›Full record

ArticleNeurosurgical review2026

Development and validation of the FLATS score to predict periprocedural ischemic events after stent-assisted coiling for ruptured intracranial aneurysms in the acute phase: a nationwide chinese registry.

Chi Huang, Hailong Zhong, Yiming Bi, Weiming Zhong, Zhuohua Wen, Yihan Chen, Chenxi Duan, Yueyi Zhang, Mengshi Huang, Zhicen Li and 16 more

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Chi Huang *Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Hailong Zhong *Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing City, People's Republic of China.
Yiming Bi *Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Weiming Zhong *Department of Neurosurgery , Shenzhen Second People's Hospital (The First Affiliated Hospital of Shenzhen University), Shenzhen City, Guangdong Province, People's Republic of China.
Zhuohua WenNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Yihan ChenThe Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Chenxi DuanThe Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Yueyi ZhangThe Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Mengshi HuangNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Zhicen LiDepartment of Neurosurgery , Shenzhen Second People's Hospital (The First Affiliated Hospital of Shenzhen University), Shenzhen City, Guangdong Province, People's Republic of China.
Wenxin ChenNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Lele DaiNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Yuanhao OuyangNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Jiwan HuangNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Shixing SuNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Xin ZhangNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Zongduo GuoDepartment of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing City, People's Republic of China.
Shuyin LiangNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Jing LiDepartment of Interventional Neuroradiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing City, People's Republic of China.
Changming WenDepartment of Neurology, Nanyang Central Hospital, Nanyang City, Henan Province, People's Republic of China.
Xiru ZhangNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Xin FengNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Xifeng LiNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China.
Songfeng GongDepartment of Neurosurgery , Shenzhen Second People's Hospital (The First Affiliated Hospital of Shenzhen University), Shenzhen City, Guangdong Province, People's Republic of China. gsf1412@163.com.
Aihua LiuDepartment of Interventional Neuroradiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing City, People's Republic of China. liuaihuadoctor@163.com.
Chuanzhi DuanNeurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases in Ministry of Education, Zhujiang Hospital, Southern Medical University, Guangzhou City, Guangdong Province, The People's Republic of China. doctor_duanzj@163.com.

Funding

Clinical Research Program of Southern Medical University dxlcyj0001Guangzhou Key Research and Development Program of Guangzhou Municipal Science and Technology Bureau 2025B03J0128National Natural Science Foundation of China 82571691Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation pdjh2025bk052
6 · The paper itself

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating stroke subtype. In the acute phase (< 72 h), stent-assisted coiling (SAC) carries a substantial risk of ischemic events (IEs). Early identification of high-risk patients is critical to improving outcomes. We developed and validated a practical risk score for predicting IEs, to support individual risk stratification. This prospective registry (SANE registry) included patients with aSAH at 33 advanced stroke centers across China from April 2021 to April 2024. Demographic, radiological and procedural variables collected at hospitalization were screened using Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression to construct a predictive risk score (FLATS). Model discrimination was assessed by the area under the receiver operating characteristic curve (AUC). An independent external validation cohort was derived from a single tertiary hospital, comprising patients treated between January 2011 and December 2020. The derivation cohort included 1,469 patients (median age: 57 years; 71.0% females) and 196 patients (13.3%) developed IEs. From 18 potential predictors, 5 variables were independent predictive factors and were included in the risk score: age, modified Fisher Scale, aneurysm size and location, and time to surgery. The FLATS score demonstrated good discriminative, with an AUC of 0.808. In external validation (n = 439), the AUC was 0.853. For risk stratification, a FLATS score > 15 was defined as high risk and a score < 10 indicated as lower risk. The FLATS score is an easily applicable aid for risk stratification of IEs after SAC for acute aSAH. 

trial registrationChiCTR2000032657 (chictr.org.cn, registered by Beijing Tiantan Hospital on May 5, 2020).

Indexed as

Aneurysm, RupturedBrain IschemiaEndovascular ProceduresIntracranial AneurysmPostoperative ComplicationsStentsSubarachnoid HemorrhageAdultAgedChinaEast Asian PeopleEmbolization, TherapeuticFemaleHumansMaleMiddle AgedIntracranial aneurysmIschemic eventsRisk scoreStent-assisted coilingSubarachnoid hemorrhage

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.